Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study.

Takanori NumataJun ArayaKeitaro OkudaHanae MiyagawaShunsuke MinagawaTakeo IshikawaHiromichi HaraKazuyoshi Kuwano

Published in: Journal of asthma and allergy (2022)

Long-term treatment with benralizumab significantly improved pulmonary function, alleviated asthma symptoms and decreased the number of exacerbations at two years in a real-world setting. The CRR may be associated with the BBC at baseline.

Keyphrases

chronic obstructive pulmonary disease
cystic fibrosis
rheumatoid arthritis
early onset
combination therapy
physical activity
depressive symptoms
sleep quality